Artigo Acesso aberto Revisado por pares

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

2011; Oxford University Press; Volume: 18; Issue: 5 Linguagem: Inglês

10.1002/ibd.21853

ISSN

1536-4844

Autores

Haruhiko Ogata, Jun Kato, Fumihito Hirai, Nobuyuki Hida, Toshiyuki Matsui, Takayuki Matsumoto, Katsuyoshi Koyanagi, Toshifumi Hibi∥,

Tópico(s)

Liver Diseases and Immunity

Resumo

BackgroundWe report a multicenter study of oral tacrolimus (FK506) therapy in steroid-refractory ulcerative colitis (UC).

Referência(s)